Clinical Trial Update: Efficacy and Safety of Travoprost 0.004% Versus Tafluprost 0.0015% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension [Phase 4]

View source ↗

Summary

Phase 4 trial comparing the efficacy and safety of Travoprost 0.004% versus Tafluprost 0.0015% in patients with primary open-angle glaucoma or ocular hypertensi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Tafluprost (tafluprost)
• Travoprost (Travoprost (isomer-free))

Snippet

Sponsor: Alcon Research | Conditions: Glaucoma | Phase 4 | Status: COMPLETED | Results posted: 2012-06-20